RSS
TRON
Cancer immunotherapy vaccine could help create personalised treatment
A clinically applicable mRNA cancer immunotherapy vaccine has been developed by BioNTech, a biotechnology company developing individualised cancer immunotherapies and TRON, the translational oncology department at the Johannes Gutenberg University Read more
